DELTICOM-B2B
30.10.2018 16:16:05 CET | Business Wire | Press release
Users of Goodride, Star Performer or Nankang tyres will be more relaxed when it comes to their wallets in the future: Many of Delticom’s B2B shops now offer a lifetime warranty on its Star Performer tires and other Delticom house brands - giving its dealers strong selling points. The warranty is valid in Germany, Austria, Switzerland, Netherlands, Sweden, Denmark, France, Spain, Italy, Poland, Portugal and Finland. In the event of manufacturing or material defects and even irreparable damage due to everyday use the tire will either be replaced at no cost or big discounts will be offered. The compensation claim depends on the remaining tread depth. For example, defective tires with a remaining tread depth of six millimeters or more will be replaced with new ones, or customers receive a discount of up to 80 percent of the current price on the day the warranty claim is made.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181030005757/en/
"Current market monitors show a trend to increasing demand for cheap tires. Star Performer, Goodride and Nankang perfectly complement a dealer's portfolio", explains Thorsten Orbach, Head of Dealer Business at Delticom B2B. "Dealers can offer price-conscious end customers, who value an excellent cost benefit ratio above all else, an excellent alternative with an attractive margin for themselves at the same time. With the lifetime guarantee, we also generate business for our dealers with Goodride, Star Performer and Nankang tires.“
Additional information about the lifetime warranty can be found in the German online shop under the following links:
https://www.autoreifenonline.de/Goodride-Reifengarantie-lifetime.html
https://www.autoreifenonline.de/Star-Performer-Reifengarantie-lifetime.html
https://www.autoreifenonline.de/Nankang-Reifengarantie-lifetime.html
About Autoreifenonline.de
Autoreifenonline.de is the
exclusive German online shop for garages, dealers, wholesalers and
service/installation stations from Delticom AG with tires of all types
and car accessories. With more than 15 years experience in online tire
business, the B2B professional team from Autoreifenonline.de offers
their business customers an outstanding range of car and motorcycle
tires of all makes and sizes for all vehicle types, light truck and
truck tires, bus tires, special tires, complete wheels, car spare parts
and accessories, engine oil and batteries. Dealers not only benefit from
good purchasing conditions, but also time-saving tire search functions
in the online shop, high availability, reliable delivery thanks to their
own warehouses, as well as easy registration and use without any hidden
costs - from the very first tire on.
Online shops for dealers and garages in Germany, Austria and Switzerland : www.autoreifenonline.de , www.autoreifenonline.at , www.autoreifenonline.ch and 24 other countries.
Information about the business : www.delti.com
Tire tests : www.reifentest.com
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005757/en/
Contact:
Press contact insignis Agentur für Kommunikation GmbH (GPRA) Henning Jahns Tel.: +49-511-132214-14 Fax: +49-511-132214-99 delticom@insignis.de or Delticom AG Anne Lena Peters Tel.: +49-511-93634-8909 Fax: +49-511-93634-8301 anne.lena.peters@delti.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom